NCT06458829

Brief Summary

Atrial fibrillation is the most common sustained cardiac arrhythmia in adults. Due to the asymptomatic and paroxysmal nature (randomly and shortly occurring of atrial fibrillation, and can therefore remain unnoticed) of atrial fibrillation. Atrial fibrillation increases the risk of stroke five fold if left untreated. Screening in old populations above age 65 years is helpful to find more atrial fibrillation cases. However, screening for atrial fibrillation is not well implemented in China. Thus, this project aims to promote atrial fibrillation screening in primary care centers in China. We will develop an intervention program (SEARCH-AF) and examine the effects (including the clinical effects and implementation effects) of program.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,800

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Jul 2024

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jul 2024Dec 2026

First Submitted

Initial submission to the registry

June 3, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 14, 2024

Completed
17 days until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Expected
Last Updated

June 14, 2024

Status Verified

June 1, 2024

Enrollment Period

12 months

First QC Date

June 3, 2024

Last Update Submit

June 10, 2024

Conditions

Keywords

Atrial FibrillationDisease screening

Outcome Measures

Primary Outcomes (1)

  • Atrial fibrillation detection rate

    Rate of newly detected atrial fibrillation. The data will be collected via medical records (primary care medical system) review and patient interview.

    End of the intervention (T0), three-month (T1) and six-month (T2) after the intervention.

Secondary Outcomes (5)

  • Anticoagulation rate

    Three-month and six-month post the intervention

  • Cost-effectiveness

    Six-month post the intervention

  • Atrial fibrillation associated events

    Three-month and six-month post the intervention

  • Atrial fibrillation related medical resource consumption

    Three-month and six-month post the intervention

  • Compliance with atrial fibrillation screening

    Three-month and six-month post the intervention

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention group will receive SEARCH-AF intervention which includes opportunistic screening and screening promoting strategies.

Behavioral: SEARCH-AF

Control group

ACTIVE COMPARATOR

All the control groups will finally receive the SEARCH-AF intervention.

Behavioral: SEARCH-AF

Interventions

SEARCH-AFBEHAVIORAL

SEARCH-AF program will include opportunistic screening among old adults during primary care visits and promoting strategies. Promoting strategies will be developed based on the Consolidated Framework for Implementation Research framework which may include leadership engagement, policy support, providing screening resources, atrial fibrillation screening and management training. General practitioner or nurse in each health care center will implement point-on-care screening. The intervention will last for six months and followed up for another six months.

Control groupIntervention group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • aged 65 years or above
  • living in community

You may not qualify if:

  • with a previous confirmed diagnosis of atrial fibrillation
  • with implanted ICD or pacemaker
  • unable to provide consent
  • involving in other atrial fibrillation screening program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Xi CAO

    Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
SEQUENTIAL
Model Details: Stepped-Wedge Cluster Randomized Trial. Six community centers will be included. There will be three steps for intervention implementation. Tat each step, two centers will be randomly assigned to receive intervention, other centers will serve as control group or maintain post-intervention status.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associated professor

Study Record Dates

First Submitted

June 3, 2024

First Posted

June 14, 2024

Study Start

July 1, 2024

Primary Completion

June 30, 2025

Study Completion (Estimated)

December 30, 2026

Last Updated

June 14, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share